Revumenib Citrate - CAS 2761046-45-9

Revumenib (also known as SNDX-5613) is an effective and selective Menin-MLL inhibitor. It is primarily used for the study of MLL-rearranged (MLL-r) acute leukemias, including acute lymphoblastic leukemia (ALL) and acute myeloid leukemia (AML) .

2760992

C38H57FN6O12S

840.96

C(CC(O)=O)(CC(O)=O)(C(O)=O)O.C(N1CCC2(CN(C2)C=3C(OC4=C(C(N(C(C)C)CC)=O)C=C(F)C=C4)=CN=CN3)CC1)[C@@H]5CC[C@@H](NS(CC)(=O)=O)CC5.O

-20°C

Ice Packs

Small Compound